Search by Drug Name or NDC

    NDC 70710-1240-09 ZITUVIO 25 mg/1 Details

    ZITUVIO 25 mg/1

    ZITUVIO is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is SITAGLIPTIN.

    Product Information

    NDC 70710-1240
    Product ID 70710-1240_d2e68080-f67c-462b-a330-45012873d719
    Associated GPIs
    GCN Sequence Number 085417
    GCN Sequence Number Description sitagliptin TABLET 25 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 54894
    HICL Sequence Number 049275
    HICL Sequence Number Description SITAGLIPTIN
    Brand/Generic Brand
    Proprietary Name ZITUVIO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Sitagliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name SITAGLIPTIN
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211566
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1240-09 (70710124009)

    NDC Package Code 70710-1240-9
    Billing NDC 70710124009
    Package 90 TABLET in 1 BOTTLE (70710-1240-9)
    Marketing Start Date 2023-11-30
    NDC Exclude Flag N
    Pricing Information N/A